Barbara E Bierer

Barbara Emily Bierer, MD

Professor of Medicine (Pediatrics), HMS
Member, HMS Center for Bioethics

Barbara Bierer, MD is a Professor of Medicine (Pediatrics) at Harvard Medical School (HMS), and a hematologist/oncologist at the Brigham and Women's Hospital (BWH). She received her MD from HMS. She is the director of the Regulatory Foundations, Law and Ethics Program of the Harvard Catalyst, the Harvard Clinical and Translational Science Award, and the director of regulatory policy, SMART IRB. Dr. Bierer co-founded and now leads the Multi-Regional Clinical Trials Center of BWH and Harvard (MRCT Center), a University-wide and collaborative effort to improve the ethics, conduct, and regulatory environment for multi-site, multi-national clinical trials. She is a co-founder of COVID-19 Collaboration Platform, a platform for cooperation in research. In 2017, the MRCT Center launched the non-profit Vivli, a global clinical research data sharing platform. From 2003-2014, she served as Senior Vice President, Research, at BWH and was the institutional official for human subjects and animal research, for biosafety and for research integrity at the BWH. She initiated the Brigham Research Institute and the Innovation Hub (iHub), a focus for entrepreneurship and innovation. Dr. Bierer established and directed the Center for Faculty Development and Diversity at the BWH; for these efforts, she was the first recipient of the HMS Harold Amos Faculty Diversity Award.

Publications View
Preparing for responsible sharing of clinical trial data.
Authors: Authors: Mello MM, Francer JK, Wilenzick M, Teden P, Bierer BE, Barnes M.
N Engl J Med
View full abstract on Pubmed
Biomedical innovation in academic institutions: mitigating conflict of interest.
Authors: Authors: Nelsen LL, Bierer BE.
Sci Transl Med
View full abstract on Pubmed
Enhancing safety reporting in adult ambulatory oncology with a clinician champion: a practice innovation.
Authors: Authors: Weingart SN, Price J, Duncombe D, Connor M, Conley K, Conlin GJ, Sullivan AM, Powell M, Ponte PR, Bierer BE.
J Nurs Care Qual
View full abstract on Pubmed
Gelsolin overexpression alters actin dynamics and tyrosine phosphorylation of lipid raft-associated proteins in Jurkat T cells.
Authors: Authors: Morley SC, Sung J, Sun GP, Martelli MP, Bunnell SC, Bierer BE.
Mol Immunol
View full abstract on Pubmed
Patient-reported safety and quality of care in outpatient oncology.
Authors: Authors: Weingart SN, Price J, Duncombe D, Connor M, Sommer K, Conley KA, Bierer BE, Ponte PR.
Jt Comm J Qual Patient Saf
View full abstract on Pubmed
Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism.
Authors: Authors: Foley JE, Jung U, Miera A, Borenstein T, Mariotti J, Eckhaus M, Bierer BE, Fowler DH.
J Immunol
View full abstract on Pubmed
Isolation and Differentiation of Stem and Progenitor Cells.
Authors: Authors: Bierer BE.
Curr Protoc Immunol
View full abstract on Pubmed
Regulation of CXCR4 expression in human T lymphocytes by calcium and calcineurin.
Authors: Authors: Cristillo AD, Bierer BE.
Mol Immunol
View full abstract on Pubmed
Cloning and characterization of N4WBP5A, an inducible, cyclosporine-sensitive, Nedd4-binding protein in human T lymphocytes.
Authors: Authors: Cristillo AD, Nie L, Macri MJ, Bierer BE.
J Biol Chem
View full abstract on Pubmed
CD28 engagement promotes actin polymerization through the activation of the small Rho GTPase Cdc42 in human T cells.
Authors: Authors: Salazar-Fontana LI, Barr V, Samelson LE, Bierer BE.
J Immunol
View full abstract on Pubmed